FOX NEWS: A newly approved gene therapy cures blindness -- but it costs nearly $1M

A newly approved gene therapy cures blindness -- but it costs nearly $1M



The Food and Drug Administration’s approval of Luxturna is the first gene therapy to treat a specific inherited gene mutation, RPE65– and has been deemed a medical milestone. Yet criticism has stirred over the near $1 million dollar price tag–making it the most expensive medicine sold in the U.S., ranked by the sticker price.